5162

    543321

    TATVA

    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    TATVA CHIN PHARM CHEM LTD Share Price Today

    TATVA CHIN PHARM CHEM LTD is currently trading at ₹1788.2, up by ₹108.0 from the previous close. The stock touched an intraday high of ₹1799.00 and a low of ₹1676.10 during the latest trading session. Over the past one year, TATVA CHIN PHARM CHEM LTD has delivered a return of 53.23%, while the stock has gained 49.72% in the last one month.

    TATVA CHIN PHARM CHEM LTD performance

    Today’s low Today’s high
    ₹ 1676.10 ₹ 1799.00
    ₹ 1788.20
    52 week low 52 week high
    ₹ 976.40 ₹ 1835.00
    ₹ 1788.20
    Open Price ₹ 1685.50
    Prev. Close ₹ 1680.20
    Volume (Shares) 179387.00
    Total traded value ₹ 3207.79
    Upper Circuit ₹ 2016.20
    Lower Circuit ₹ 1344.20
    info

    Investment Returns

    Over 1 Month 49.72% Over 3 Months 36.39% Over 6 Months 64.02% Over 1 Year 53.23%
    Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    TATVA CHIN PHARM CHEM LTD fundamentals


    • Market cap (Cr) 4,183.00
    • P/E Ratio (TTM) 94.37
    • Beta 1.32
    • Book Value / share 324.14
    • Return on equity 0.05%
    • EPS (TTM) 19.40
    • Dividend yield 0.11%
    • Net profit/quarter (Cr) 10.45
    info icon alternate text
    • Market cap (Cr) 4,190.00
    • P/E Ratio (TTM) 94.37
    • Beta 1.24
    • Book Value / share 324.14
    • Return on equity 0.05%
    • EPS (TTM) 19.40
    • Dividend yield 0.11%
    • Net profit/quarter (Cr) 10.45
    info icon alternate text

    TATVA CHIN PHARM CHEM LTD Financials

    Open financial information
    Revenue
    Net income
    Particulars JUN 2026 (Values in Cr)
    Revenue 146.70
    Operating Expense 135.32
    Net Profit 10.45
    Net Profit Margin (%) 7.12
    Earnings Per Share (EPS) 4.47
    EBITDA 26.74
    Effective Tax Rate (%) 25.90
    Particulars MAR 2026 (Values in Cr)
    Revenue 132.67
    Operating Expense 117.32
    Net Profit 9.02
    Net Profit Margin (%) 6.79
    Earnings Per Share (EPS) 3.86
    EBITDA 26.17
    Effective Tax Rate (%) 39.71
    Particulars DEC 2025 (Values in Cr)
    Revenue 138.59
    Operating Expense 121.53
    Net Profit 15.98
    Net Profit Margin (%) 11.53
    Earnings Per Share (EPS) 6.84
    EBITDA 28.34
    Effective Tax Rate (%) 14.95
    Particulars SEP 2025 (Values in Cr)
    Revenue 115.86
    Operating Expense 104.32
    Net Profit 8.94
    Net Profit Margin (%) 7.71
    Earnings Per Share (EPS) 3.82
    EBITDA 21.90
    Effective Tax Rate (%) 27.55
    Particulars JUN 2025 (Values in Cr)
    Revenue 109.18
    Operating Expense 103.49
    Net Profit 5.13
    Net Profit Margin (%) 4.69
    Earnings Per Share (EPS) 2.19
    EBITDA 16.43
    Effective Tax Rate (%) 27.23
    Particulars MAR 2026 (Values in Cr)
    Revenue 496.30
    Operating Expense 446.66
    Net Profit 39.08
    Net Profit Margin (%) 7.87
    Earnings Per Share (EPS) 16.71
    EBITDA 92.86
    Effective Tax Rate (%) 26.48
    Particulars MAR 2025 (Values in Cr)
    Revenue 366.42
    Operating Expense 369.52
    Net Profit 0.33
    Net Profit Margin (%) 0.09
    Earnings Per Share (EPS) 0.14
    EBITDA 29.40
    Effective Tax Rate (%) 28.26
    Particulars MAR 2024 (Values in Cr)
    Revenue 378.68
    Operating Expense 343.92
    Net Profit 29.35
    Net Profit Margin (%) 7.75
    Earnings Per Share (EPS) 12.82
    EBITDA 74.38
    Effective Tax Rate (%) 30.56
    Particulars MAR 2023 (Values in Cr)
    Revenue 403.04
    Operating Expense 366.30
    Net Profit 40.47
    Net Profit Margin (%) 10.04
    Earnings Per Share (EPS) 18.26
    EBITDA 56.76
    Effective Tax Rate (%) -4.19
    Particulars MAR 2022 (Values in Cr)
    Revenue 427.81
    Operating Expense 335.17
    Net Profit 95.99
    Net Profit Margin (%) 22.43
    Earnings Per Share (EPS) 44.65
    EBITDA 116.40
    Effective Tax Rate (%) 7.04
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 315.84
    ROE % 0.77
    ROCE % 1.19
    Total Debt to Total Equity 0.03
    EBITDA Margin 9.60
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 315.10
    ROE % 4.85
    ROCE % 6.99
    Total Debt to Total Equity 0.15
    EBITDA Margin 19.29
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 232.25
    ROE % 9.21
    ROCE % 8.34
    Total Debt to Total Equity 0.29
    EBITDA Margin 14.86
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 213.44
    ROE % 30.00
    ROCE % 25.64
    Total Debt to Total Equity 0.33
    EBITDA Margin 27.07
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 82.62
    ROE % 36.85
    ROCE % 27.90
    Total Debt to Total Equity 0.64
    EBITDA Margin 23.93
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 308.36
    ROE % 0.05
    ROCE % 0.25
    Total Debt to Total Equity 0.04
    EBITDA Margin 8.07
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 310.31
    ROE % 4.77
    ROCE % 6.90
    Total Debt to Total Equity 0.15
    EBITDA Margin 19.68
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 227.74
    ROE % 8.31
    ROCE % 7.48
    Total Debt to Total Equity 0.30
    EBITDA Margin 14.12
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 211.54
    ROE % 30.43
    ROCE % 25.71
    Total Debt to Total Equity 0.33
    EBITDA Margin 27.26
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 80.61
    ROE % 37.16
    ROCE % 27.74
    Total Debt to Total Equity 0.65
    EBITDA Margin 24.21
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 14.09
    Total Assets 836.24
    Total Liabilities 836.24
    Total Equity 738.82
    Share Outstanding 2
    Price to Book Ratio 2.20
    Return on Assets (%) 0.68
    Return on Capital (%) 0.74
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 38.29
    Total Assets 818.71
    Total Liabilities 818.71
    Total Equity 737.08
    Share Outstanding 2
    Price to Book Ratio 3.48
    Return on Assets (%) 3.70
    Return on Capital (%) 4.04
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 44.76
    Total Assets 758.85
    Total Liabilities 758.85
    Total Equity 514.79
    Share Outstanding 2
    Price to Book Ratio 7.32
    Return on Assets (%) 5.99
    Return on Capital (%) 6.64
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 176.98
    Total Assets 658.30
    Total Liabilities 658.30
    Total Equity 473.08
    Share Outstanding 2
    Price to Book Ratio 10.91
    Return on Assets (%) 14.56
    Return on Capital (%) 16.17
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 5.34
    Total Assets 314.80
    Total Liabilities 314.80
    Total Equity 165.96
    Share Outstanding 2
    Price to Book Ratio 0.00
    Return on Assets (%) 16.60
    Return on Capital (%) 20.4
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 11.92
    Total Assets 822.80
    Total Liabilities 822.80
    Total Equity 721.31
    Share Outstanding 2
    Price to Book Ratio 2.20
    Return on Assets (%) 0.03
    Return on Capital (%) 0.04
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 36.97
    Total Assets 815.06
    Total Liabilities 815.06
    Total Equity 725.88
    Share Outstanding 2
    Price to Book Ratio 3.48
    Return on Assets (%) 3.60
    Return on Capital (%) 3.97
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 38.58
    Total Assets 754.85
    Total Liabilities 754.85
    Total Equity 504.78
    Share Outstanding 2
    Price to Book Ratio 7.32
    Return on Assets (%) 5.36
    Return on Capital (%) 5.99
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 174.74
    Total Assets 676.20
    Total Liabilities 676.20
    Total Equity 468.87
    Share Outstanding 2
    Price to Book Ratio 10.91
    Return on Assets (%) 14.19
    Return on Capital (%) 16.3
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 3.58
    Total Assets 309.68
    Total Liabilities 309.68
    Total Equity 161.93
    Share Outstanding 2
    Price to Book Ratio 0.00
    Return on Assets (%) 16.58
    Return on Capital (%) 20.37
    Particulars MAR 2025 (Values in Cr)
    Net Income 7.57
    Cash from Operations 29.16
    Cash from Investing -65.25
    Cash from Financing 16.56
    Net change in Cash -24.01
    Free Cash Flow 105.44
    Particulars MAR 2024 (Values in Cr)
    Net Income 43.56
    Cash from Operations 106.60
    Cash from Investing -120.54
    Cash from Financing 30.51
    Net change in Cash 8.02
    Free Cash Flow 235.12
    Particulars MAR 2023 (Values in Cr)
    Net Income 44.77
    Cash from Operations 37.07
    Cash from Investing -101.14
    Cash from Financing 37.79
    Net change in Cash -35.56
    Free Cash Flow 240.18
    Particulars MAR 2022 (Values in Cr)
    Net Income 104.12
    Cash from Operations 38.78
    Cash from Investing -196.80
    Cash from Financing 234.96
    Net change in Cash 58.53
    Free Cash Flow 127.94
    Particulars MAR 2021 (Values in Cr)
    Net Income 60.69
    Cash from Operations 29.50
    Cash from Investing -20.65
    Cash from Financing -4.71
    Net change in Cash -5.67
    Free Cash Flow 50.47
    Particulars MAR 2025 (Values in Cr)
    Net Income 0.46
    Cash from Operations 28.34
    Cash from Investing -65.25
    Cash from Financing 16.56
    Net change in Cash -24.78
    Free Cash Flow 104.61
    Particulars MAR 2024 (Values in Cr)
    Net Income 42.26
    Cash from Operations 109.25
    Cash from Investing -120.54
    Cash from Financing 30.54
    Net change in Cash 12.78
    Free Cash Flow 237.76
    Particulars MAR 2023 (Values in Cr)
    Net Income 38.83
    Cash from Operations 31.47
    Cash from Investing -101.12
    Cash from Financing 37.81
    Net change in Cash -39.57
    Free Cash Flow 234.55
    Particulars MAR 2022 (Values in Cr)
    Net Income 103.26
    Cash from Operations 37.72
    Cash from Investing -196.68
    Cash from Financing 235.01
    Net change in Cash 58.04
    Free Cash Flow 126.88
    Particulars MAR 2021 (Values in Cr)
    Net Income 59.34
    Cash from Operations 28.72
    Cash from Investing -20.61
    Cash from Financing -4.71
    Net change in Cash -6.42
    Free Cash Flow 49.69
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    ATUL LTD. 6732.90 24.92 3.18 19822.84 5563.00 7198.20
    BASF INDIA LTD 3636.45 38.10 3.97 15740.61 2906.90 5040.75
    ORIENTAL AROMATICS LIMITED 368.00 232.91 1.86 1238.45 227.05 403.85
    DEEPAK FERTILISERS & PETROCHEM 1552.70 19.92 2.86 19600.95 865.45 1677.85
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    ADVANCE PETROCHEMICALS LTD. 164.30 497.88 3.72 14.79 97.60 320.75
    ATUL LTD. 6732.90 28.39 3.27 19822.84 5563.00 7198.20
    BASF INDIA LTD 3636.45 38.40 3.95 15740.61 2906.90 5040.75
    ORIENTAL AROMATICS LIMITED 368.00 44.71 1.76 1238.45 227.05 403.85

    TATVA CHIN PHARM CHEM LTD shareholding pattern

    Holding
    20.93%
    72.02%
    3.93%
    3.1%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    TATVA CHIN PHARM CHEM LTD Technicals Summary

    1788.20 6.42 redarrow
    red-green-graph indicator
    0 Bearish
    16 Bullish
    • 5 Days 1734.40
    • 26 Days 1519.40
    • 10 Days 1681.00
    • 50 Days 1407.80
    • 12 Days 1656.30
    • 100 Days 1326.90
    • 20 Days 1568.40
    • 200 Days 1258.00
    1696.60 PIVOT
    First Support 1646.10 First Resistance 1730.70 Second Support 1612.00 Second Resistance 1781.20 Third Support 1561.50 Third Resistance 1815.30
    RSI 70.49 ADX 69.41 MACD 136.93 Williams % R -10.07 Commodity Channel Index (CCI) 80.25
    Date 2026-07-31 Week 55133.00 Same Day 69143.00 Month 63965.00
    1 Year 1.33 3 Year 0.71
    Over 1 Month
    49.72% down
    Over 1 Year
    53.23% down
    Over 3 Months
    36.39% down
    Over 3 Years
    2.88% down
    Over 6 Months
    64.02% down
    Over 5 Years
    -4.60% down

    TATVA CHIN PHARM CHEM LTD Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    12 Sep 2025 1.0 Final 12 Sep 2025 Equity shares
    06 Sep 2024 2.0 Final 07 Sep 2024 Equity shares
    08 Sep 2023 2.0 Final 08 Sep 2023 Equity shares
    08 Sep 2022 2.0 Final 09 Sep 2022 Equity shares
    Dividend date Dividend amount Dividend type Record date Instrument type
    12 Sep 2025 1.0 Final 12 Sep 2025 Equity shares
    06 Sep 2024 2.0 Final 07 Sep 2024 Equity shares
    08 Sep 2023 2.0 Final 08 Sep 2023 Equity shares
    08 Sep 2022 2.0 Final 09 Sep 2022 Equity shares

    Top Gainers

    Top Losers

    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Tatva Chintan Pharma Chem Ltd?

    Answer Field

    Tatva Chintan Pharma Chem Ltd share price is for NSE ₹ 1,788.20 & for BSE ₹ 1,780.00 as on Jul 31 2026 03:30 PM.

    What is the Market Cap of Tatva Chintan Pharma Chem Ltd Share?

    Answer Field

    The market cap of Tatva Chintan Pharma Chem Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 31 2026 03:30 PM.

    What is the 52 Week High and Low of Tatva Chintan Pharma Chem Ltd?

    Answer Field

    The 52 Week High and Low of Tatva Chintan Pharma Chem Ltd for NSE is ₹ 1,835.00 and ₹ 976.40 and for BSE is ₹ 1,832.80 and ₹ 977.85.

    What is 1 year return for Tatva Chintan Pharma Chem Ltd?

    Answer Field

    The 1 year returns on the stock has been 53.23%.

    What is the P/E Ratio of Tatva Chintan Pharma Chem Ltd Share?

    Answer Field

    As on Jul 31 2026 03:30 PM the price-to-earnings (PE) ratio for Tatva Chintan Pharma Chem Ltd share is 94.37.

    What is the PB ratio of Tatva Chintan Pharma Chem Ltd Share?

    Answer Field

    As on Jul 31 2026 03:30 PM, the price-to-book (PB) ratio for Tatva Chintan Pharma Chem Ltd share is 324.14.

    How to Buy Tatva Chintan Pharma Chem Ltd Share?

    Answer Field

    You can trade in Tatva Chintan Pharma Chem Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Tatva Chintan Pharma Chem Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Tatva Chintan Pharma Chem Ltd shares on the Bajaj Broking app, follow these steps:

    1. Login to the Bajaj Broking App

    2. Click on the Search Icon

    3. Search “Tatva Chintan Pharma Chem Ltd”

    4. Click on the BUY icon

    5. Place a buy order specifying the desired quantity of shares.

    6. Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |